Death by TNF: a road to inflammation

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Tumour necrosis factor (TNF) is a key cytokine in inflammatory and autoimmune diseases.
• Biologics targeting TNF are effective treatments for these conditions.
• Emerging evidence shows TNF also induces inflammatory responses indirectly through cell death pathways.

Purpose of the Study:

• To explore the role of TNF-induced cell death in inflammatory diseases.
• To evaluate the potential of cell death inhibitors as a novel therapeutic strategy for TNF-dependent inflammatory conditions.

Main Methods:

• Review of current literature on TNF signaling and cell death mechanisms.
• Analysis of preclinical and clinical data on TNF inhibitors and cell death inhibitors.

Main Results:

• TNF directly promotes inflammation via gene expression.
• TNF indirectly exacerbates inflammation by triggering cell death, which instigates further immune reactions.
• Cell death inhibition emerges as a viable therapeutic approach.

Conclusions:

• Targeting TNF-induced cell death offers a new avenue for treating inflammatory and autoimmune diseases.
• Cell death inhibitors represent a potential next-generation therapy for TNF-driven pathologies.